Cargando…

A 98-Year-Old Male With Paroxysmal Atrial Fibrillation Treated for COVID-19 at Home

In the absence of evidenced-based guidelines for early home treatment of COVID-19, some Italian groups of volunteer physicians (both general practitioners (GPs) and hospital doctors) virtually gathered themselves to discuss the best available evidence and develop shared schemes of therapy. We presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Farolfi, Fabrizia, Cavazza, Stefania, Mangiagalli, Andrea, Cavanna, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681671/
https://www.ncbi.nlm.nih.gov/pubmed/36426345
http://dx.doi.org/10.7759/cureus.30653
_version_ 1784834666708074496
author Farolfi, Fabrizia
Cavazza, Stefania
Mangiagalli, Andrea
Cavanna, Luigi
author_facet Farolfi, Fabrizia
Cavazza, Stefania
Mangiagalli, Andrea
Cavanna, Luigi
author_sort Farolfi, Fabrizia
collection PubMed
description In the absence of evidenced-based guidelines for early home treatment of COVID-19, some Italian groups of volunteer physicians (both general practitioners (GPs) and hospital doctors) virtually gathered themselves to discuss the best available evidence and develop shared schemes of therapy. We present the case of a 98-year-old unvaccinated male on chronic anticoagulant therapy with dabigatran for paroxysmal atrial fibrillation (AF), who has been successfully treated for COVID-19 at home, according to one of the multidrug treatments proposed, since hospital admission was not feasible. At the very beginning of symptoms, anti-inflammatory drugs, vitamin D, and adjuvant dietary supplements (quercetin, vitamin C, zinc, and vitamin K2) were administered, followed by dexamethasone and antibiotic therapy, according to the evolving clinical conditions. Gastroprotection with omeprazole was added. Eventually, our patient fully recovered, thus suggesting that careful home assistance under strict medical supervision can be successful, even in a very old subject with comorbidities, particularly if early treatment simultaneously addressing inflammation, hypercoagulation, and viral replication is started.
format Online
Article
Text
id pubmed-9681671
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-96816712022-11-23 A 98-Year-Old Male With Paroxysmal Atrial Fibrillation Treated for COVID-19 at Home Farolfi, Fabrizia Cavazza, Stefania Mangiagalli, Andrea Cavanna, Luigi Cureus Family/General Practice In the absence of evidenced-based guidelines for early home treatment of COVID-19, some Italian groups of volunteer physicians (both general practitioners (GPs) and hospital doctors) virtually gathered themselves to discuss the best available evidence and develop shared schemes of therapy. We present the case of a 98-year-old unvaccinated male on chronic anticoagulant therapy with dabigatran for paroxysmal atrial fibrillation (AF), who has been successfully treated for COVID-19 at home, according to one of the multidrug treatments proposed, since hospital admission was not feasible. At the very beginning of symptoms, anti-inflammatory drugs, vitamin D, and adjuvant dietary supplements (quercetin, vitamin C, zinc, and vitamin K2) were administered, followed by dexamethasone and antibiotic therapy, according to the evolving clinical conditions. Gastroprotection with omeprazole was added. Eventually, our patient fully recovered, thus suggesting that careful home assistance under strict medical supervision can be successful, even in a very old subject with comorbidities, particularly if early treatment simultaneously addressing inflammation, hypercoagulation, and viral replication is started. Cureus 2022-10-25 /pmc/articles/PMC9681671/ /pubmed/36426345 http://dx.doi.org/10.7759/cureus.30653 Text en Copyright © 2022, Farolfi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Family/General Practice
Farolfi, Fabrizia
Cavazza, Stefania
Mangiagalli, Andrea
Cavanna, Luigi
A 98-Year-Old Male With Paroxysmal Atrial Fibrillation Treated for COVID-19 at Home
title A 98-Year-Old Male With Paroxysmal Atrial Fibrillation Treated for COVID-19 at Home
title_full A 98-Year-Old Male With Paroxysmal Atrial Fibrillation Treated for COVID-19 at Home
title_fullStr A 98-Year-Old Male With Paroxysmal Atrial Fibrillation Treated for COVID-19 at Home
title_full_unstemmed A 98-Year-Old Male With Paroxysmal Atrial Fibrillation Treated for COVID-19 at Home
title_short A 98-Year-Old Male With Paroxysmal Atrial Fibrillation Treated for COVID-19 at Home
title_sort 98-year-old male with paroxysmal atrial fibrillation treated for covid-19 at home
topic Family/General Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681671/
https://www.ncbi.nlm.nih.gov/pubmed/36426345
http://dx.doi.org/10.7759/cureus.30653
work_keys_str_mv AT farolfifabrizia a98yearoldmalewithparoxysmalatrialfibrillationtreatedforcovid19athome
AT cavazzastefania a98yearoldmalewithparoxysmalatrialfibrillationtreatedforcovid19athome
AT mangiagalliandrea a98yearoldmalewithparoxysmalatrialfibrillationtreatedforcovid19athome
AT cavannaluigi a98yearoldmalewithparoxysmalatrialfibrillationtreatedforcovid19athome
AT farolfifabrizia 98yearoldmalewithparoxysmalatrialfibrillationtreatedforcovid19athome
AT cavazzastefania 98yearoldmalewithparoxysmalatrialfibrillationtreatedforcovid19athome
AT mangiagalliandrea 98yearoldmalewithparoxysmalatrialfibrillationtreatedforcovid19athome
AT cavannaluigi 98yearoldmalewithparoxysmalatrialfibrillationtreatedforcovid19athome